.png&w=256&q=75)
Encourages students to think creatively.
Professor Austin Stack serves as Chair of Medicine at the University of Limerick's Graduate Entry Medical School and Consultant Nephrologist at University Hospital Limerick. He earned his MB BCh BAO from University College Dublin in 1991, completing medical residency and early nephrology training in Ireland. He pursued advanced fellowship training in Nephrology and Transplantation at the University of Michigan from 1996 to 1999, followed by an MSc in Clinical Research Design and Statistical Analysis from the University of Michigan School of Public Health and an MD in Medicine (Epidemiology) awarded in 2005. His career trajectory includes serving as Assistant Professor at the University of Texas Medical School in Houston in 2002, promotion to Associate Professor in 2007, and appointment as Consultant Nephrologist in Ireland's Northwest region from 2005. In 2012, he joined the University of Limerick as Professor and Chair of Medicine.
Professor Stack's research focuses on the epidemiology, risk factors, clinical outcomes, and treatment strategies for chronic kidney disease (CKD) and acute kidney injury (AKI), including their relationships with cardiovascular diseases, dialysis modalities, mineral bone disease, gout, and hyperuricaemia. He has received Health Research Board grants to study CKD and AKI epidemiology within the Irish health system, leading the development of Ireland's first National Surveillance System for kidney disease in partnership with the Health Service Executive, University of Michigan, and University College Cork. Notable publications include 'Association of elevated serum PO4, Ca×PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients' (2001, Journal of the American Society of Nephrology), 'Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial' (2019, The Lancet), 'Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States' (2003, American Journal of Kidney Diseases), and 'Prevalence and determinants of chronic kidney disease among community-dwelling adults, 50 years and older in Ireland' (2025, Clinical Kidney Journal). His work utilizes large datasets such as the US Renal Data System to inform preventive strategies, enhance patient outcomes, and advance health system performance through big data and connected health approaches.